scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF01808547 |
P698 | PubMed publication ID | 7942182 |
P2093 | author name string | T Wakabayashi | |
K Sugita | |||
J Yoshida | |||
Y Kajita | |||
P2860 | cites work | Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery | Q33483488 |
Magnetic resonance imaging of the brain and spine. Is clinical efficacy established after the first decade? | Q36444770 | ||
Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. | Q38652757 | ||
Statistical analysis of factors affecting survival after glioblastoma multiforme | Q40081916 | ||
Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection with the tumor necrosis factor-alpha gene | Q41576337 | ||
Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody | Q41710577 | ||
Radioimmunoassay of glioma-associated antigen in cerebrospinal fluid and its usefulness for the diagnosis and monitoring of human glioma | Q41744823 | ||
Effects of ACNU and radiotherapy on malignant glioma | Q43990390 | ||
Long-time survival of a patient with glioblastoma and Turcot's syndrome | Q44053227 | ||
The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4. | Q48667459 | ||
Cytotoxicity of human beta-interferon produced in human glioma cells transfected with its gene by means of liposomes | Q54257568 | ||
Giant cell glioblastoma: a work-up of 2 cases with long survival. | Q55485486 | ||
Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. | Q55486820 | ||
Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. | Q55487073 | ||
Clinical effect of interferon in malignant brain tumours. | Q55488998 | ||
Mechanism of the Antitumour Effect of Interferon in Mice | Q59078562 | ||
In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line (HeLa) | Q72724704 | ||
P433 | issue | 1-2 | |
P304 | page(s) | 55-59 | |
P577 | publication date | 1994-01-01 | |
P1433 | published in | Acta Neurochirurgica | Q15749688 |
P1476 | title | Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation | |
P478 | volume | 127 |
Q58644234 | A Ratiometric Fluorescence Imaging System for Surgical Guidance |
Q55463398 | A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report. |
Q32048073 | A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas |
Q44352425 | A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas |
Q55475071 | Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma. |
Q35781959 | An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals |
Q40928411 | Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse |
Q43723424 | Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma |
Q99551805 | Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells |
Q87421956 | Brain PDD and PDT unlocking the mystery of malignant gliomas |
Q37886819 | Cytokine networks in glioma |
Q35800815 | Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization |
Q47969589 | Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: effect of tumor extirpation |
Q47794847 | Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells |
Q55463752 | High-Field iMRI in Glioblastoma Surgery: Improvement of Resection Radicality and Survival for the Patient? |
Q46415677 | Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas |
Q42465800 | In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. |
Q49129466 | Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma |
Q47817635 | Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells |
Q55456847 | Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death. |
Q54252845 | JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. |
Q37013025 | Management of glioblastoma |
Q43196861 | Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth |
Q35939650 | Microsurgery for malignant gliomas |
Q28375678 | O6-(fluorobenzyl)guanine and chloroethylnitrosourea in xenografted rat brain tumor in vivo |
Q33346938 | Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme |
Q43505054 | Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes |
Q46878705 | Quantitation of O6-methylguanine-DNA methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas |
Q47192395 | Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction |
Q36115400 | Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system |
Q55476501 | The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. |
Q40368455 | Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA. |
Q55481232 | Therapy of glioblastoma multiforme: a cumulative experience of 10 years. |
Q48371856 | Treatment of low-grade diffuse astrocytomas by surgery and human fibroblast interferon without radiation therapy |
Q37330706 | Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme |
Search more.